ALK's tablet-based vaccine against grass allergy, GRAZAX, has been awarded "Product of the Year" by The Confederation of Danish Industry. GRAZAX is the first allergy tablet to treat the underlying cause of the allergic disease as well as the symptoms.
The product award is presented once a year by The Confederation of Danish Industry with a view to honouring companies for developing excellent customer solutions. To be eligible for the product award, the product must have been developed by a Danish company within the past five years, and be exceptionally groundbreaking.